Loovi

What They Do

Preventive health and longevity platform offering clinical-grade biomarker testing, doctor consultations, and personalised health plans. Tests 120+ biomarkers annually via drop-in blood draws at 80+ clinic locations across Sweden. Results within 3 days, followed by unrushed 1-on-1 doctor consultations and ongoing chat support with a dedicated health team.

Founders

Dr. Kevin Najafi — Co-Founder & COO. Physician with ER background. Focused on preventive medicine after seeing the end-stage effects of lifestyle diseases in emergency care.
Joel Grajcer — Co-Founder & CEO. Started optimizing personal health through bloodwork and realized data alone isn't clarity — built Loovi to translate biomarker data into actionable long-term plans.

Product

Membership: 295 SEK/month (standard: 590 SEK/month). Onboarding fee: 1,995 SEK.
Testing: 60+ biomarkers per blood draw at 80+ drop-in clinic locations
Consultation: Unrushed 1-on-1 with longevity doctors
Ongoing: Unlimited chat with health team, retesting every 6 months, personalised supplement/fitness/nutrition plan
Corporate: Approved for Swedish Friskvårdsbidrag (wellness benefit)
Philosophy: "Health Power Laws" — finding the 20% of effort that delivers 80% of results. Focus on early detection, cardiovascular fitness, muscle strength, metabolic health.

Revenue

Org nr: 559459-5893 Source: allabolag.se

2024: 273K SEK (~€24K) — first full fiscal year
Loss 2024: -790K SEK
Employees: 5-9
Assets: 1,428K SEK
Equity: 1,235K SEK
Cash liquidity: 739.9% (very strong)
Solvency: 86.5% (very good)

Funding

Valuation: Not publicly disclosed. €1M Seed round (Feb 2026) per EU-Startups. Investors: Not disclosed. Source: Stockholm-based Loovi secures €1 million to scale preventive health and longevity platform — EU-Startups (Feb 2026)

Traction

80+ clinic locations for drop-in testing across Sweden
Website live at loovi.health with waitlist
Active social media (Instagram, Facebook, LinkedIn)
Approved for Friskvårdsbidrag (Swedish employer wellness benefit) — key B2B2C channel
Early stage: only 273K SEK revenue in 2024, but 5-9 employees suggests building for scale

Competitive Position

Targets the gap between ultra-expensive longevity clinics (100K+ SEK/year) and generic "eat better" advice. Subscription model (295-590 SEK/month) makes proactive health accessible. Competes with:

Neko Health — AI body scanning (different approach, less biomarker depth)
Nightingale Health — blood biomarker platform (B2B focus vs Loovi B2C)
Traditional health checks (Previa, etc.)

Business Details

Founded: 2023
Total Funding: €1M Seed (Feb 2026)
Valuation: Not disclosed
Revenue: 273K SEK (2024)
Employees: 5-9
Key Milestones: 80+ clinic locations. 295 SEK/month subscription. Friskvårdsbidrag approved.